arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Assembly Biosciences, Inc.

ASMB Health Care Biotechnology: Pharmaceutical Preparations
$19.84
▼ -3.0% Today
as of Oct 23, 16:46 ET
Last 30 days -31.49% Sep 14 → Oct 23
$19.11 $21.76 $24.40 $27.04 $29.69 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$20.34
High
$20.34
Low
$19.30
Volume
$206,013
Avg Vol
$180,644
Mkt Cap
$468M
P/E (TTM)
—
Beta
—
52w High
$39.71
52w Low
$19.30
Div Yield
—
Shares Out
$20M

Recent Press Releases & News last 60 days · 9 items

Oct 5 · 16:48 MT Newswires
Assembly Biosciences Plans to Present Posters Featuring New Phase 1a Data From ABI-6250 Program
Oct 5 · 14:00 PR GlobeNewswire
Assembly Biosciences to Present Positive Phase 1a Safety, Tolerability and Target Engagement Data for ABI-6250 at AASLD The Liver Meeting® 2026
Sep 10 · 20:15 PR GlobeNewswire
Assembly Biosciences to Present at the H.C. Wainwright & Co. 28th Annual Global Investment Conference
▸ Show all 9 press releases & news Free account →

ASMB earnings at a glance

The options market is pricing a move of about ±14.6% after the report, a range of roughly $16.94 to $22.74 from today's $19.84. Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±3.7% on average; after the most recent report on May 7, 2026 it moved -1.4%. That means options currently expect more movement than ASMB has typically delivered. ASMB beat the consensus EPS estimate in 2 of its last 3 reported quarters. Implied volatility is currently 117%. The share price of $19.84 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$19
$40
3% of range
Avg surprise (last 3)
+7.9%
Avg reaction (last 2)
-3.7%
0% positive
Latest IV / EM
117%
EM ±14.6% · $23 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-4.46$-3.40$-2.33$-1.27$-0.20 Actual $-4.46Actual $-3.88Actual $-3.29Actual $-1.66Actual $-1.98Actual $-1.51Actual $-1.17Est $-2.01Actual $-1.33Actual $-0.72Est $-0.50Actual $-0.54Est $-0.73Actual $-0.20 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-10M$-4M$2M$8M$14M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.20 — — — — financials
Thu May 7, 2026Mar/2026 $-0.54 $-0.73 +26.0% +53.9% -1.4% earnings
Mon Nov 10, 2025Sep/2025 $-0.72 $-0.50 -44.0% — — earnings
Wed Aug 6, 2025Jun/2025 $-1.33 — — — — earnings
Thu May 8, 2025Mar/2025 $-1.17 $-2.01 +41.8% — -6.0% earnings
Mon Sep 30, 2024Sep 2024 $-1.51 — — — — financials
Sun Jun 30, 2024Jun 2024 $-1.98 — — — — financials
Sun Mar 31, 2024Mar 2024 $-1.66 — — — — financials
Sat Sep 30, 2023Sep 2023 $-3.29 — — — — financials
Fri Jun 30, 2023Jun 2023 $-3.88 — — — — financials
Fri Mar 31, 2023Mar 2023 $-4.46 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$13M$8M—$11M$10M$9M—$7M
Cost of revenue————————
Gross profit————————
Operating income$-6M$-11M—$-11M$-11M$-10M—$-11M
Net income$-4M$-9M—$-9M$-10M$-9M—$-10M
EPS (diluted)$-0.20$-0.54—$-0.72$-1.33$-1.17—$-1.51

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$32M$31M$58M$23M$24M$23M$38M$28M
Inventory————————
Total current assets$328M$233M$255M$237M$77M$96M$116M$98M
Total assets$331M$236M$258M$240M$81M$99M$119M$100M
Long-term debt————————
Total liabilities$25M$37M$51M$57M$63M$72M$86M$74M
Total equity$306M$199M$207M$183M$18M$27M$33M$26M

Implied volatility — last 90 days

25%142%260%378%495% Jun 08 — IV 131% · EM ±17.3%Jun 09 — IV 112% · EM ±14.1%Jun 10 — IV 52% · EM ±6.2%Jun 11 — IV 193% · EM ±21.3%Jun 15 — IV 326% · EM ±23.6%Jun 17 — IV 496% · EM ±20.7%Jun 19 — IV 68% · EM ±15.0%Jun 22 — IV 111% · EM ±23.3%Jun 23 — IV 86% · EM ±17.5%Jun 24 — IV 115% · EM ±23.0%Jun 25 — IV 103% · EM ±20.2%Jun 26 — IV 106% · EM ±20.2%Jun 29 — IV 87% · EM ±15.4%Jun 30 — IV 127% · EM ±21.8%Jul 01 — IV 124% · EM ±20.8%Jul 02 — IV 131% · EM ±21.2%Jul 03 — IV 96% · EM ±15.1%Jul 06 — IV 136% · EM ±18.9%Jul 07 — IV 128% · EM ±16.9%Jul 08 — IV 139% · EM ±17.4%Jul 09 — IV 96% · EM ±11.4%Jul 10 — IV 114% · EM ±12.6%Jul 13 — IV 36% · EM ±3.0%Jul 14 — IV 263% · EM ±19.1%Jul 20 — IV 83% · EM ±19.7%Jul 21 — IV 98% · EM ±22.9%Jul 22 — IV 91% · EM ±20.7%Jul 23 — IV 76% · EM ±17.1%Jul 24 — IV 96% · EM ±21.1%Jul 27 — IV 70% · EM ±14.7%Jul 28 — IV 67% · EM ±13.8%Jul 29 — IV 99% · EM ±19.9%Jul 30 — IV 102% · EM ±19.9%Jul 31 — IV 87% · EM ±16.6%Aug 03 — IV 111% · EM ±19.7%Aug 04 — IV 91% · EM ±15.6%Aug 05 — IV 91% · EM ±15.2%Aug 06 — IV 81% · EM ±13.1%Aug 07 — IV 84% · EM ±13.1%Aug 10 — IV 146% · EM ±20.2%Aug 11 — IV 150% · EM ±19.8%Aug 12 — IV 159% · EM ±20.0%Aug 13 — IV 99% · EM ±11.7%Aug 14 — IV 154% · EM ±17.0%Aug 17 — IV 80% · EM ±6.7%Aug 18 — IV 157% · EM ±11.4%Aug 19 — IV 153% · EM ±9.0%Aug 20 — IV 357% · EM ±14.9%Aug 24 — IV 55% · EM ±11.4%Aug 25 — IV 74% · EM ±15.1%Aug 26 — IV 59% · EM ±11.9%Aug 27 — IV 54% · EM ±10.5%Aug 28 — IV 58% · EM ±11.0%Aug 31 — IV 49% · EM ±8.6%Sep 01 — IV 70% · EM ±12.0%Sep 02 — IV 51% · EM ±8.6%Sep 03 — IV 62% · EM ±10.0%Sep 08 — IV 63% · EM ±8.3%Sep 09 — IV 130% · EM ±16.3%Sep 10 — IV 126% · EM ±14.9%Sep 15 — IV 294% · EM ±21.3%Sep 21 — IV 73% · EM ±15.3%Sep 22 — IV 65% · EM ±13.4%Sep 23 — IV 96% · EM ±19.2%Sep 24 — IV 72% · EM ±14.1%Sep 25 — IV 71% · EM ±13.6%Sep 28 — IV 25% · EM ±4.4%Sep 29 — IV 134% · EM ±23.0%Sep 30 — IV 127% · EM ±21.3%Oct 01 — IV 135% · EM ±21.8%Oct 02 — IV 143% · EM ±22.3%Oct 05 — IV 160% · EM ±22.1%Oct 06 — IV 68% · EM ±9.0%Oct 07 — IV 117% · EM ±14.6%

Sector peers

EVMN
Evommune, Inc.
$472M $5.10-1.4%
DMAC
DiaMedica Therapeutics Inc.
$450M $8.72+0.3%
ARVN
Arvinas, Inc.
$487M $7.30-3.4%
ACRS
Aclaris Therapeutics, Inc.
$500M $3.75-1.6%
CBIO
Crescent Biopharma, Inc.
$501M $12.82-2.7%
PBYI
Puma Biotechnology Inc
$506M $11.02+1.1%

ASMB earnings FAQ

What is ASMB's expected move for earnings?

Options currently price a move of about ±14.6%, or $2.90 per share either way from $19.84.

How does ASMB stock usually react to earnings?

Across the last 2 reports the average next-day move was ±3.7%, up 0 times and down 2 times.

What is ASMB's implied volatility?

ASMB's at-the-money implied volatility is about 117% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in